Custom service
Cyclic Peptide Characterization
Characterize cyclic peptides: topology, isomerism, stability and aggregation
Teams come to this service when they need to characterize cyclic peptides: topology, isomerism, stability and aggregation. We typically start from MS/MS connectivity mapping, add NMR-based conformation analysis where the application demands it, and close the loop with serum and protease stability assays so the final characterization report with connectivity assignment behaves consistently across lots.
Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 2–4 weeks timeline holds in practice.
Confirming ring topology after external synthesis
Pre-IND characterization packages
Characterization requiring isotopically labeled NMR samples
Cycles whose ring size is known to be geometrically uncloseable
Cyclic products are released against connectivity, not mass alone. MS/MS fragmentation confirms the ring closure, and where multiple topologies are possible the target isomer is isolated and its ratio reported. Protease-stability data are available as an add-on.
Service Highlights
- MS/MS connectivity mapping as the default route, with NMR-based conformation analysis held as a proven fallback
- Serum and protease stability assays worked into the design where the application requires it
- Cyclization strategy (head-to-tail, disulfide, lactam, thioether) chosen from a feasibility screen, not fixed by habit
- Analytical confirmation of every intermediate before the final release
- Cyclic/linear and topological isomers separated and reported, with the target isomer identified by MS/MS
- Characterization report with connectivity assignment delivered with a complete conjugation or synthesis certificate
How the work runs
Precursor design
Linear precursor, cyclization sites and protecting strategy are designed around the Cyclic Peptide Characterization ring size.
Linear assembly
The precursor chain is assembled with Fmoc chemistry and MS/MS connectivity mapping where relevant.
Cyclization
Ring closure is executed by NMR-based conformation analysis under screened dilution and activation conditions.
Isomer separation
RP-HPLC resolves cyclic/linear and topological isomers; the target isomer is collected.
Characterization
Connectivity, purity and identity are confirmed by MS/MS and HPLC against the specification.
Release
Characterization report with connectivity assignment is documented and released after QC sign-off.
Specifications & timeline
- Turnaround
- 2–4 weeks
- Typical scale
- 1 – 200 mg cyclic peptide
- Chemistry options
- MS/MS connectivity mapping; NMR-based conformation analysis; serum and protease stability assays
- Deliverable
- Characterization report with connectivity assignment
- QC package
- HPLC purity, MS/MS connectivity proof, isomer ratio, DMSO solubility
- Shipping
- Ambient with desiccant; blue ice for sensitive motifs
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.